Psychedelic Research Revival
The discussion highlights the complexities surrounding neurogenesis and its therapeutic implications, revealing that not all neurogenic compounds yield beneficial effects. It also explores the historical context of psychedelic research, emphasizing that the decline in interest was not solely due to government restrictions but also a lack of funding and pharmaceutical backing. With renewed interest from pharmaceutical companies, there is hope for a resurgence in psychedelic research that could unlock their potential as medical treatments.In this clip
From this podcast
The Joe Rogan Experience
Joe Rogan Experience #1615 - Hamilton Morris
Related Questions